New combined microRNA and protein plasmatic biomarker panel for pancreatic cancer
Wei Yuan(Shanghai Public Health Clinical Center), Jie Ma(Tianjin University of Traditional Chinese Medicine), Wanyan Tang(Chongqing University), Shaoming Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Yingtai Chen(Shanghai Jiao Tong University), Yibin Xie(Chinese Academy of Medical Sciences & Peking Union Medical College), Jun Qi(Hong Kong Baptist University), You‐Lin Qiao(Chinese Academy of Medical Sciences & Peking Union Medical College)
Cited by 34
Related Papers
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
|New England Journal of Medicine|2015|2.2k
Olaparib in patients with metastatic castration-resistant prostate cancer with DNA repair gene aberrations (TOPARP-B): a multicentre, open-label, randomised, phase 2 trial
|The Lancet Oncology|2019|649
Prostate-specific Membrane Antigen Heterogeneity and DNA Repair Defects in Prostate Cancer
|European Urology|2019|464
Circulating Cell-Free DNA to Guide Prostate Cancer Treatment with PARP Inhibition
|Cancer Discovery|2017|422
Variations in the age‐specific curves of human papillomavirus prevalence in women worldwide
|International Journal of Cancer|2006|417